Cme (CME) Net Income towards Common Stockholders (2009 - 2026)

Cme (CME) has 18 years of Net Income towards Common Stockholders data on file, last reported at $1.2 billion in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $1.2 billion, up 23.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 billion (up 18.53% YoY), and the FY2025 annual result was $4.0 billion, up 15.5% from the prior year.
• Net Income towards Common Stockholders was little changed at $1.2 billion in Q1 2026 per CME's latest filing, from $1.2 billion in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $1.2 billion in Q4 2025 and troughed at $630.0 million in Q4 2022.
• A 5-year average of $853.7 million and a median of $863.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders retreated 27.57% in 2022, then soared 35.23% in 2025.
• A 5-year view of Net Income towards Common Stockholders shows it stood at $630.0 million in 2022, then advanced by 27.67% to $804.3 million in 2023, then climbed by 7.39% to $863.7 million in 2024, then soared by 35.23% to $1.2 billion in 2025, then changed by 0.0% to $1.2 billion in 2026.
• Business Quant data shows CME's Net Income towards Common Stockholders at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $896.6 million in Q3 2025.